ATE532507T1 - Neramexane zur behandlung von subakuten tinnitus - Google Patents

Neramexane zur behandlung von subakuten tinnitus

Info

Publication number
ATE532507T1
ATE532507T1 AT08801987T AT08801987T ATE532507T1 AT E532507 T1 ATE532507 T1 AT E532507T1 AT 08801987 T AT08801987 T AT 08801987T AT 08801987 T AT08801987 T AT 08801987T AT E532507 T1 ATE532507 T1 AT E532507T1
Authority
AT
Austria
Prior art keywords
neramexane
treatment
subacute
tinnitus
subacute tinnitus
Prior art date
Application number
AT08801987T
Other languages
English (en)
Inventor
Barbara Ellers-Lenz
Tanja Rosenberg
Hagen Krueger
Michael Althaus
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Application granted granted Critical
Publication of ATE532507T1 publication Critical patent/ATE532507T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Percussion Or Vibration Massage (AREA)
AT08801987T 2007-09-12 2008-09-10 Neramexane zur behandlung von subakuten tinnitus ATE532507T1 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US99339607P 2007-09-12 2007-09-12
EP07253630 2007-09-12
US6702608P 2008-02-25 2008-02-25
US6708308P 2008-02-25 2008-02-25
US6693108P 2008-02-25 2008-02-25
EP08004777 2008-03-14
EP08004776 2008-03-14
EP08004778 2008-03-14
PCT/EP2008/007421 WO2009033652A1 (en) 2007-09-12 2008-09-10 1-amino-alkylcyclohexane derivatives for the treatment of cochlear tinnitus

Publications (1)

Publication Number Publication Date
ATE532507T1 true ATE532507T1 (de) 2011-11-15

Family

ID=40451596

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08801987T ATE532507T1 (de) 2007-09-12 2008-09-10 Neramexane zur behandlung von subakuten tinnitus

Country Status (21)

Country Link
US (6) US9498450B2 (de)
EP (6) EP2200598A1 (de)
JP (6) JP5613053B2 (de)
KR (4) KR20100052557A (de)
CN (4) CN101801365A (de)
AR (3) AR070026A1 (de)
AT (1) ATE532507T1 (de)
AU (4) AU2008298017B2 (de)
BR (2) BRPI0816690A2 (de)
CA (4) CA2699210A1 (de)
DK (1) DK2200600T3 (de)
ES (5) ES2510565T3 (de)
HR (1) HRP20120046T1 (de)
MX (4) MX2010002733A (de)
PL (1) PL2200600T3 (de)
PT (1) PT2200600E (de)
RU (1) RU2011137131A (de)
SI (1) SI2200600T1 (de)
TW (3) TW200927087A (de)
WO (4) WO2009033652A1 (de)
ZA (4) ZA201001261B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010002733A (es) * 2007-09-12 2010-04-09 Merz Pharma Gmbh & Co Kgaa Terapia de intervalo para el tratamiento de tinnitus.
US20110294890A1 (en) * 2010-05-28 2011-12-01 Merz Pharma Gmbh & Co. Kgaa Neramexane for the treatment or prevention of inner ear disorders
WO2011160839A1 (en) 2010-06-24 2011-12-29 Merz Pharma Gmbh & Co. Kgaa Neramexane multiple unit dosage form
JP6084931B2 (ja) * 2011-01-20 2017-02-22 メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン ストレス又は急性聴力損失に関連する耳鳴の治療又は予防のためのネラメキサン
EP2964249A1 (de) * 2013-03-06 2016-01-13 Acorda Therapeutics, Inc. Therapeutische dosierung eines neuregulins oder eines fragments davon zur behandlung oder prophylaxe von herzversagen
JP5978471B2 (ja) * 2014-04-28 2016-08-24 杏林製薬株式会社 耳鳴患者の治療用の薬剤
AU2015254241A1 (en) * 2014-04-28 2016-11-10 Kyorin Pharmaceutical Co., Ltd. Drug for treatment of tinnitus patients
CA2999467C (en) 2014-10-23 2023-10-10 Arena Pharmaceuticals, Inc. Method of treating conditions related to the pgi2 receptor
PL3297628T3 (pl) * 2015-05-18 2021-12-06 Sensorion Azasetron do stosowania w leczeniu niedosłuchu
KR101893604B1 (ko) 2015-08-27 2018-08-30 경희대학교 산학협력단 칸디다 유틸리스 추출물을 포함하는 난청의 예방 또는 치료용 조성물
CN105924362B (zh) * 2016-02-05 2018-08-17 上海龙翔生物医药开发有限公司 芳香环丙基胺类化合物、其药学上可接受的盐、其制备方法及其用途
KR102432505B1 (ko) 2017-03-01 2022-08-12 아레나 파마슈티칼스, 인크. Pgi2-수용체 효능제를 포함하는 조성물 및 그의 제조 방법
KR102268893B1 (ko) 2020-01-16 2021-06-24 경북대학교 산학협력단 림노트릭스 속 knua002 균주를 포함하는 난청의 예방 또는 치료용 조성물
CN111477199B (zh) * 2020-04-02 2021-11-30 北京瑞迪欧文化传播有限责任公司 一种嵌入式音乐控制系统

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024983A (en) 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
US4849222A (en) 1987-03-24 1989-07-18 The Procter & Gamble Company Mixtures for treating hypercholesterolemia
JP2670680B2 (ja) 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
US5288502A (en) 1991-10-16 1994-02-22 The University Of Texas System Preparation and uses of multi-phase microspheres
JPH09504027A (ja) 1993-10-22 1997-04-22 ジェネンテク，インコーポレイテッド ワクチンとしての使用のための抗原のマイクロカプセル化のための方法および組成物
DE19528388A1 (de) * 1995-08-02 1997-02-06 Hans Peter Prof Dr Med Zenner Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
AU4424697A (en) 1996-09-11 1998-04-02 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The The use of functional n-methyl-d-aspartate antagonists to ameliorate or prevent aminoglycoside-induced ototoxicity
US6071966A (en) 1997-06-30 2000-06-06 Merz + Co. Gmbh & Co. 1-amino-alkylcyclohexane NMDA receptor antagonists
JP3963488B2 (ja) * 1997-06-30 2007-08-22 メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツンク ウント コンパニー コマンディゲゼルシャフト アウフ アクチェン １−アミノ−アルキルシクロヘキサンｎｍｄａ受容体拮抗薬
ES2267759T3 (es) * 2000-04-26 2007-03-16 Warner-Lambert Company Llc Trans-n-4-(4-hidroxifenil) ciclohexili-3-fenilpropionamida como antagonista selectivo de subtipos de receptores nmda.
DE10048969A1 (de) * 2000-08-23 2002-03-14 Mueller Schwefe Gerhard Verwendung von Flupirtin zur Tinnitusbehandlung
US20030236288A1 (en) * 2002-02-28 2003-12-25 Karl Schoenafinger Use of substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadizol-2-ones for inhibiting pancreatic lipase
JP2004021734A (ja) 2002-06-18 2004-01-22 Nokia Corp キーパッドおよびキーパッドシステム
US7086532B2 (en) * 2003-07-16 2006-08-08 Allergan, Inc. Titration/compliance pack with increasing doses
JP2006502158A (ja) * 2002-09-06 2006-01-19 デュレクト コーポレーション グルタメート媒介神経伝達のモジュレーターの内耳への送達
DE10252665A1 (de) 2002-11-11 2004-06-03 Grünenthal GmbH 4-Aminomethyl-1-aryl-cyclohexylamin-Derivate
KR20060030469A (ko) * 2003-05-27 2006-04-10 포레스트 래보러토리즈, 인코포레이티드 우울증 및 그 밖의 기분장애의 치료를 위한 ｎｍｄａ수용체 길항제 및 선택적 세로토닌 재흡수 억제제의 배합물
AR046314A1 (es) 2003-11-05 2005-11-30 Merz Pharma Gmbh & Co Kgaa Composiciones que comprenden ciclohexilaminas y aminoadamantanos
EA011290B1 (ru) 2004-06-17 2009-02-27 Мерц Фарма Гмбх Унд Ко. Кгаа Препаративные формы пероральных лекарственных форм мемантина с немедленным высвобождением
US20060002999A1 (en) 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
US20060205822A1 (en) * 2004-12-22 2006-09-14 Forest Laboratories, Inc. 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
CA2594963A1 (en) * 2005-01-24 2006-07-27 Neurosystec Corporation Apparatus and method for delivering therapeutic and/or other agents to the inner ear and to other tissues
EP2932971A1 (de) * 2005-03-04 2015-10-21 Otonomy, Inc. Ketaminformulierungen
TWI265036B (en) * 2005-04-29 2006-11-01 Guo-Ming Huang Safety injector and method of operating the same
CN101175458B (zh) * 2005-05-18 2010-08-18 Gt泌尿学公司 可植入失禁用设备的药物洗脱
CN1896729A (zh) 2005-07-15 2007-01-17 复旦大学附属中山医院 纳米药物自组装双稳态量子线阵列及其制备方法
US20070141148A1 (en) * 2005-11-30 2007-06-21 Merz Pharma Gmbh & Co. Kgaa Neramexane MR matrix tablet
TW200819458A (en) * 2006-06-23 2008-05-01 Merz Pharma Gmbh & Co Kgaa Metabotropic glutamate receptor modulators
MX2010002733A (es) * 2007-09-12 2010-04-09 Merz Pharma Gmbh & Co Kgaa Terapia de intervalo para el tratamiento de tinnitus.
TW201010691A (en) * 2008-06-12 2010-03-16 Merz Pharma Gmbh & Co Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
TW201006463A (en) * 2008-06-26 2010-02-16 Merz Pharma Gmbh & Co Kgaa Pharmaceutical compositions comprising aminocyclohexane derivatives
CN102123703A (zh) * 2008-09-10 2011-07-13 莫茨药物股份两合公司 用于治疗耳鸣中认知损害的1-氨基-烷基环己烷衍生物
US20110294890A1 (en) * 2010-05-28 2011-12-01 Merz Pharma Gmbh & Co. Kgaa Neramexane for the treatment or prevention of inner ear disorders
JP6084931B2 (ja) * 2011-01-20 2017-02-22 メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン ストレス又は急性聴力損失に関連する耳鳴の治療又は予防のためのネラメキサン

Also Published As

Publication number Publication date
ZA201001263B (en) 2011-07-27
EP2548552B1 (de) 2015-11-18
MX2010002734A (es) 2010-04-01
JP5563461B2 (ja) 2014-07-30
JP2010539115A (ja) 2010-12-16
JP2010539117A (ja) 2010-12-16
DK2200600T3 (da) 2012-01-23
US8877814B2 (en) 2014-11-04
JP5784188B2 (ja) 2015-09-24
AR070025A1 (es) 2010-03-10
EP2200599A1 (de) 2010-06-30
TW200927087A (en) 2009-07-01
US20100298441A1 (en) 2010-11-25
AU2008298016B2 (en) 2012-02-02
EP2548552A3 (de) 2013-10-16
JP5784189B2 (ja) 2015-09-24
US20150018425A1 (en) 2015-01-15
AR070026A1 (es) 2010-03-10
JP5612473B2 (ja) 2014-10-22
EP2203163A1 (de) 2010-07-07
EP2386299B1 (de) 2016-07-13
JP5563460B2 (ja) 2014-07-30
CA2699209A1 (en) 2009-03-19
JP2014221766A (ja) 2014-11-27
AU2008298017A1 (en) 2009-03-19
ZA201001262B (en) 2011-07-27
US20110077304A1 (en) 2011-03-31
EP2203163B1 (de) 2014-08-27
AU2008298017B2 (en) 2012-03-01
US20110086916A1 (en) 2011-04-14
AU2008298018C1 (en) 2012-08-16
ES2596262T3 (es) 2017-01-05
MX2010002733A (es) 2010-04-09
PT2200600E (pt) 2012-02-17
ES2510565T3 (es) 2014-10-21
HRP20120046T1 (hr) 2012-02-29
ZA201001261B (en) 2011-08-31
CN101801366A (zh) 2010-08-11
US20170027885A1 (en) 2017-02-02
WO2009033651A1 (en) 2009-03-19
BRPI0816690A2 (pt) 2016-11-01
AU2008298018B2 (en) 2012-01-19
JP2010539116A (ja) 2010-12-16
AU2008298018A1 (en) 2009-03-19
KR20100052556A (ko) 2010-05-19
CA2699213A1 (en) 2009-03-19
CA2699210A1 (en) 2009-03-19
MX2010002735A (es) 2010-04-01
US20100298440A1 (en) 2010-11-25
EP2200600B1 (de) 2011-11-09
SI2200600T1 (sl) 2012-03-30
ES2377253T3 (es) 2012-03-23
EP2548552A2 (de) 2013-01-23
ZA201001264B (en) 2011-07-27
AU2008298015A1 (en) 2009-03-19
EP2200598A1 (de) 2010-06-30
ES2604945T3 (es) 2017-03-10
MX2010002736A (es) 2010-04-01
TW200922544A (en) 2009-06-01
WO2009033649A1 (en) 2009-03-19
EP2200599B1 (de) 2016-08-31
CN101795679A (zh) 2010-08-04
WO2009033652A1 (en) 2009-03-19
EP2200600A1 (de) 2010-06-30
EP2386299A2 (de) 2011-11-16
JP5613053B2 (ja) 2014-10-22
CN101801365A (zh) 2010-08-11
KR20100052558A (ko) 2010-05-19
CN101835469A (zh) 2010-09-15
JP2010539118A (ja) 2010-12-16
WO2009033650A1 (en) 2009-03-19
BRPI0816712A2 (pt) 2016-11-08
AR071728A1 (es) 2010-07-14
US9468610B2 (en) 2016-10-18
RU2011137131A (ru) 2013-03-20
AU2008298015B2 (en) 2012-03-22
US9498450B2 (en) 2016-11-22
JP2014221767A (ja) 2014-11-27
TW200918042A (en) 2009-05-01
ES2562709T3 (es) 2016-03-07
EP2386299A3 (de) 2012-05-02
CA2699207A1 (en) 2009-03-19
KR20100052559A (ko) 2010-05-19
KR20100052557A (ko) 2010-05-19
PL2200600T3 (pl) 2012-04-30
AU2008298016A1 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
ATE532507T1 (de) Neramexane zur behandlung von subakuten tinnitus
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
BRPI0920104A2 (pt) tratamento de soluções ou de águas residuais
ATE545418T1 (de) Zusammensetzungen und kits zur behandlung von influenza
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
ATE550329T1 (de) Heterobicyclische sulfonamidderivate zur behandlung von diabetes
LTC2330892I2 (lt) Gydymo būdai panaudojant vaistus - amoniako gaudykles
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
SE0702104L (sv) Förfarande för behandling av avfall
ATE521365T1 (de) Kinin-antagonisten zur behandlung von blasenfunktionsstörung
FI20085275A0 (fi) Menetelmä biomassan käsittelemiseksi
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
DK2330887T3 (da) Behandlingsindretning
ATE502944T1 (de) 2-amino-5,7-dihydro-6h-pyrroloä3,4- düpyrimidinderivate als hsp-90-inhibitoren zur behandlung von krebs
DE112010005017A5 (de) Beta-carboline zur behandlung von hörschäden und schwindel
ATE525904T1 (de) Behandlung von bananen
BRPI0912687A2 (pt) uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia
BRPI0916079A2 (pt) tratamento de água marinha residual
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
ATE504297T1 (de) Visnadin zur behandlung von kopfhautjucken
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
ATE516805T1 (de) Medikament zur behandlung von endometriose
DK2297047T3 (da) Indretning til rensning af spildevand
DK2293810T3 (da) Muteret tat-oyi-protein til forebyggelse eller behandling af aids